Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Immunology
Fator do impacto: 1.404 FI de cinco anos: 3.347 SJR: 0.706 SNIP: 0.55 CiteScore™: 2.19

ISSN Imprimir: 1040-8401
ISSN On-line: 2162-6472

Volume 40, 2020 Volume 39, 2019 Volume 38, 2018 Volume 37, 2017 Volume 36, 2016 Volume 35, 2015 Volume 34, 2014 Volume 33, 2013 Volume 32, 2012 Volume 31, 2011 Volume 30, 2010 Volume 29, 2009 Volume 28, 2008 Volume 27, 2007 Volume 26, 2006 Volume 25, 2005 Volume 24, 2004 Volume 23, 2003 Volume 22, 2002 Volume 21, 2001 Volume 20, 2000 Volume 19, 1999 Volume 18, 1998 Volume 17, 1997 Volume 16, 1996 Volume 15, 1995 Volume 14, 1994

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.v18.i1-2.90
pages 77-86

Tumor-Specific Immune Response: Current In Vitro Analyses May Not Reflect the In Vivo Immune Status

Florence Faure
Biologie Moleculaire du Gene, U.277 INSERM, Institut Pasteur, 25 rue du Dr. Roux, 75724 Paris, cedex 15, France; lnstitut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif cedex, France
Jos Even
Biologie Moleculaire du Gene, U.277 INSERM, Institut Pasteur, 25 rue du Dr. Roux, 75724 Paris, cedex 15, France
Philippe Kourilsky
Biologie Moleculaire du Gene, U.277 INSERM, Institut Pasteur, 25 rue du Dr. Roux, 75724 Paris, cedex 15, France


Although our knowledge and understanding of tumor-specific cytotoxic T lymphocytes (CTL) have expanded considerably, the long-term work needed to assay CTL has precluded their analysis in large numbers of patients. Moreover, in vitro culture steps may introduce major biases. New approaches to identify tumor-specific CTL clones would be helpful. As a means to describe the in situ immune status by T-cell repertoire analysis, we developed the Immunoscope approach, a PCR-based method that allows us to determine the spectra of CDR3 lengths of the TCR chains displayed by complex populations of T cells. We review here some of our data about melanoma. Tumor-infiltrating lymphocytes of a melanoma patient were analyzed by different means and melanoma-specific T-cell clones were derived. Two categories of tumor-specific CD8+ CTL clones were derived from the infiltrate of a tumor-proximal invaded lymph node. The majority of T-cell clones specifically lyse the autologous tumor cell lines and predominantly recognize the HLA-A2/MART-127.35 peptide complex. The in vivo representativity of such CTL was assessed by the immunoscope technology. Among three MART- 1-specific clones, none was detectable in situ. The other kind of tumor-specific CD8+ CTL did not lyse autologous melanoma cell lines but lysed the “fresh” autologous tumor cells in a MHC class I dependent manner. The immunoscope approach revealed that one of the latter was detectable in situ among tumor-infiltrating lymphocytes although not among PBMC. These data indicate that melanoma-specific lymphocytes that could not have been selected through conventional screening procedures may be important in tumor rejection. Our results suggest that a better characterization of tumor-specific immune responses will be important for the optimization of specific immunotherapy strategies and the long-term follow-up of patients.

Articles with similar content:

Progress Toward Antibody-Induced Transplantation Tolerance
Critical Reviews™ in Immunology, Vol.27, 2007, issue 2
James I. Kim, Heidi Yeh, Major Kenneth Lee IV, Shaoping Deng, Samsher Sonawane, Daniel J. Moore, James F. Markmann
T-Cell Adoptive Therapy of Tumors: Mechanisms of Improved Therapeutic Performance
Critical Reviews™ in Immunology, Vol.21, 2001, issue 1-3
Brian J. Czerniecki, Jorgen Kjaergaard, Liaomin Peng, Peter A. Cohen, Gary K. Koski, James H. Finke, Suyu Shu, Gregory E. Plautz
Immunogenicity of Dendritic-Tumor Fusion Hybrids and Their Utility in Cancer Immunotherapy
Critical Reviews™ in Immunology, Vol.27, 2007, issue 5
Rongxiu Zheng, Peter A. Cohen, Suyu Shu, Walter T. Lee
Multiple Defects of Natural Killer Cells in Cancer Patients: Anarchy, Dysregulated Systemic Immunity, and Immunosuppression in Metastatic Cancer
Critical Reviews™ in Immunology, Vol.40, 2020, issue 2
Tamara Lah Turnsek, Barbara Breznik, Meng-Wei Ko, Kristin Y. Nguyen, Janko Kos, Kawaljit Kaur, Anahid Jewett, Paul Wong, Emanuela Senjor
CD8+ T Cell−Independent Immune-Mediated Mechanisms of Anti-Tumor Activity
Critical Reviews™ in Immunology, Vol.35, 2015, issue 2
G Elizabeth Pluhar, Christopher A. Pennell, Michael R. Olin